Description

This antibody was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.

Formulation

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis as negative control. Use at concentrations comparable to those of the specific antibody of interest.

Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.

References

1. Lesley R, et al. 2006. P. Natl. Acad. Sci. USA 103:10717.
2. Yu R, et al. 2006. Obesity 14:1353.
3. Yang JH, et al.2005. Rheumatology(Oxford). 44:1245. PubMed
3. Mina-Osorio P, et al. 2008. J. Leukocyte Biol. 84:448. PubMed
4. Shen H, et al. 2009. J. Am Soc Nephrol. 20:1032. PubMed